News
Author: Janice S. Sung, MD, FSBIa Background: Limitations of screening mammography Mammography is the primary imaging modality used for breast cancer screening, as it is cost effective, widely available, and the only imaging modality validated by multiple randomized controlled trials and... Continue Reading
Author: Amy M. Fowler, MD, PhD Molecular imaging is a promising approach for achieving precision medicine. It can provide important functional information for improved diagnosis, treatment planning, prognostic and predictive information and evaluation of treatment response for cancer patients. The... Continue Reading
Author: Wendie A. Berg, MD, PhD, FACR, FSBI Adapted with permission from: Journal of Nuclear Medicine (Berg WA. Nuclear breast imaging: clinical results and future directions. Journal of Nuclear Medicine. 2016 Feb 1;57(Supplement 1):46S-52S.) Summarized by: Heidi Umphrey, MD, MS, FCAP Department... Continue Reading
Authors: Emily F. Conant, MD, FSBI; Liane Philpotts, MD, FSBI Digital breast tomosynthesis (DBT), which was FDA approved in 2011, is rapidly emerging as the new standard of care for x-ray imaging of the breast. Multiple studies have shown that when DBT is coupled with conventional 2D mammography,... Continue Reading